Gerald L. Ray & Associates’s St Jude Medical STJ Stock Holding History

Gerald L. Ray & Associates’s Portfolio STJ Stock Details STJ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-2,800	Closed	-$225K	–	324
2016 Q4	$225K	Hold	2,800	–	–	0.03%	288
2016 Q3	$223K	Hold	2,800	–	–	0.03%	293
2016 Q2	$219K	Buy	+2,800	New	+$200K	0.04%	282
2015 Q3	–	Sell	-2,800	Closed	-$205K	–	315
2015 Q2	$205K	Buy	+2,800	New	+$202K	0.03%	300
2014 Q2	–	Sell	-3,300	Closed	-$216K	–	307
2014 Q1	$216K	Hold	3,300	–	–	0.04%	270
2013 Q4	$204K	Buy	+3,300	New	+$191K	0.04%	263

Other funds holding STJ

FPF

FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return

JWA

JFS Wealth Advisors Hermitage, Pennsylvania $2.01B AUM 21.74% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return

AIM

Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Gerald L. Ray & Associates's STJ Position: Q1 2017 in Review

Gerald L. Ray & Associates sold out of St Jude Medical (STJ) in Q1 2017, closing a stake of 2,800 shares — an estimated $225K sold.

Gerald L. Ray & Associates first reported a position in STJ in Q4 2013 and held it in 6 quarters. The position peaked at $225K in Q4 2016. 4 funds tracked by Wall St. Rank hold STJ as of Q1 2017.

Gerald L. Ray & Associates reported no remaining St Jude Medical position as of Q1 2017 after selling out during the quarter.
Gerald L. Ray & Associates sold 2,800 St Jude Medical shares in Q1 2017, an estimated $225K.
Gerald L. Ray & Associates first reported a position in St Jude Medical in Q4 2013 and held it in 6 quarters.
Gerald L. Ray & Associates's St Jude Medical position peaked at $225K in Q4 2016.
4 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2017.

Based on Gerald L. Ray & Associates's 13F filing for Q1 2017, filed 3 May 2017.